Assessment of the effectiveness of Budesonide MMX<sup>®</sup> for active, mild-to-moderate ulcerative colitis in the Polish sub-group of the CORE Practice prospective multi-centre observational study.

Jesionowski, Maciej; Rydzewska, Grazyna; Danese, Silvio; Paridaens, Kristine

Assessment of the effectiveness of Budesonide MMX^® for active, mild-to-moderate ulcerative colitis in the Polish sub-group of the CORE Practice prospective multi-centre observational study.

Jesionowski, Maciej; Rydzewska, Grazyna; Danese, Silvio; Paridaens, Kristine.

Afiliación

Jesionowski M; Medical Affairs Ferring Pharmaceuticals Poland, Warsaw, Poland.
Rydzewska G; Department of Internal Medicine and Gastroenterology with Inflammatory Bowel Disease Unit, Central Clinical Hospital of the Ministry of the Interior and Administration, Warsaw, Poland.
Danese S; Collegium Medicum, Jan Kochanowski University, Kielce, Poland.
Paridaens K; Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milano, Italy.

Prz Gastroenterol ; 18(2): 154-160, 2023.

Article en En | MEDLINE | ID: mdl-37538282

Palabras clave

Budesonide MMX®; Core Practice study; induction of remission in mild-to-moderate UC; polish cohort; real-life setting; ulcerative colitis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Evaluation_studies / Observational_studies Aspecto: Patient_preference Idioma: En Revista: Prz Gastroenterol Año: 2023 Tipo del documento: Article País de afiliación: Polonia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google